RxCelerate launch Galaxy™: a next-generation antibody discovery platform

Leading UK drug developer RxCelerate opens first US base in Boston

RxCelerate acquires Total Scientific Ltd

RxCelerate acquires The Cambridge Partnership Ltd

RxCelerate Opens UK-Based Chemistry Operations

RxCelerate acquires Prosarix

RxCelerate Expands

IMMUNOLOGY & INFLAMMATION

NEUROSCIENCE

ONCOLOGY